SCHEMBL28032115

SCHEMBL28032115

CCCCC(C=O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.48
PNMT P11086 1/20 0.43
TAS1R3 Q7RTX0 1/20 0.42
TAS1R1 Q7RTX1 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2D6 P10635 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
ACP3 P15309 2/20 0.40
CES2 O00748 1/20 0.40
PTGES O14684 1/20 0.40
ALOX5 P09917 1/20 0.40
PPARG P37231 1/20 0.40
PPARA Q07869 1/20 0.40
ALDH1A1 P00352 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27173414 0.82 CYP3A4 (0.39) EPHX1CYP1A2CYP3A4CYP2C9CYP2D6
SCHEMBL27173344 0.80 CHRM2 (0.41)
SCHEMBL14402570 0.79 PNMT (0.64) EPHX1PNMTTAS1R3TAS1R1HDAC3
SCHEMBL1213326 0.79 EPHX1 (0.49) EPHX1PNMTTAS1R3TAS1R1HDAC3
SCHEMBL20342674 0.79 PNMT (0.64) EPHX1PNMTTAS1R3TAS1R1HDAC3
SCHEMBL27511992 0.79 PNMT (0.47) EPHX1PNMTCYP1A2CYP3A4CYP2C9
SCHEMBL1730600 0.78 EPHX1 (0.51) EPHX1PNMTTAS1R3TAS1R1HDAC3
SCHEMBL21124992 0.78 EPHX1 (0.48) EPHX1PNMTTAS1R3TAS1R1HDAC3
SCHEMBL18885350 0.78 EPHX1 (0.48) EPHX1PNMTTAS1R3TAS1R1HDAC3
SCHEMBL7384477 0.78 EPHX1 (0.48) EPHX1PNMTTAS1R3TAS1R1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104918942-A Pyrimidone derivatives and their use for treating, ameliorating or preventing viral diseases SAVIRA PHARMACEUTICALS GMBH 2015-09-16 CN disclosed